Literature DB >> 3141718

Expression of intermediate filaments and synaptophysin show neuronal properties and lack of glial characteristics in Y79 retinoblastoma cells.

I Virtanen1, T Kivelä, M Bugnoli, C Mencarelli, V Pallini, D M Albert, A Tarkkanen.   

Abstract

The expression of intermediate filaments and synaptophysin in Y79 retinoblastoma cells was studied. The cells grew normally in suspension as floating aggregates. Sodium butyrate and dibutyryl cyclic AMP induced adherence and rapid spreading of Y79 cells on laminin-coated substratum and many of the cells presented long cellular extensions. As judged by immunostaining with monoclonal and polyclonal antibodies, most untreated Y79 cells expressed synaptophysin, whereas only vimentin intermediate filaments were detected in a few cells. A more bright fibrillar vimentin-positivity, which responded by coiling to disruption of microtubules, could be seen in the spread cells. Furthermore, especially when exposed to butyrate, a distinct fibrillar positivity could be revealed in some of the spread cells with antibodies recognizing a phosphorylated epitope in neurofilaments. Western blotting results showed the presence of the molecular weight 57,000 vimentin polypeptide and the molecular weight 38,000 synaptophysin polypeptide in both undifferentiated and spread Y79 cells, and a phosphorylated molecular weight 200,000 neurofilament polypeptide in spread cells only. In contrast, both immunostaining and Western blotting results with several antibodies indicated lack of glial fibrillary acidic protein in Y79 cells suggesting hence, a lack of glial differentiation. The present results do not support the hypothesis that retinoblastomas would originate from a common precursor cell of neurons and glia, and show the presence of mainly neuronal features in Y79 retinoblastoma cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141718

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  Tumor-associated retinal astrocytes promote retinoblastoma cell proliferation through production of IGFBP-5.

Authors:  Xiaoliang L Xu; Thomas C Lee; Nneka Offor; Christine Cheng; Aihong Liu; Yuqiang Fang; Suresh C Jhanwar; David H Abramson; David Cobrinik
Journal:  Am J Pathol       Date:  2010-05-27       Impact factor: 4.307

2.  Spinal cord-notochord relationship in normal human embryos and in a human embryo with double spinal cord.

Authors:  M Saraga-Babić; V Stefanović; J Wartiovaara; E Lehtonen
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

3.  Neuronal and glial properties of a murine transgenic retinoblastoma model.

Authors:  T Kivelä; I Virtanen; D M Marcus; J M O'Brien; J L Carpenter; E Brauner; A Tarkkanen; D M Albert
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

4.  Neuroblastic differentiation potential of the human retinoblastoma cell lines Y-79 and WERI-Rb1 maintained in an organ culture system. An immunohistochemical, electron microscopic, and biochemical study.

Authors:  M M Herman; E Perentes; C D Katsetos; F Darcel; A Frankfurter; V P Collins; L A Donoso; L F Eng; P J Marangos; A F Wiechmann
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

5.  Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling.

Authors:  Xiaoliang L Xu; Yuqiang Fang; Thomas C Lee; Douglas Forrest; Cheryl Gregory-Evans; Dena Almeida; Aihong Liu; Suresh C Jhanwar; David H Abramson; David Cobrinik
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

6.  Chorionic gonadotropin and its receptor are both expressed in human retina, possible implications in normal and pathological conditions.

Authors:  Sladjana Dukic-Stefanovic; Jan Walther; Sebastian Wosch; Gerolf Zimmermann; Peter Wiedemann; Henry Alexander; Thomas Claudepierre
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

7.  Efficient photodynamic therapy on human retinoblastoma cell lines.

Authors:  Jan Walther; Stanislas Schastak; Sladjana Dukic-Stefanovic; Peter Wiedemann; Jochen Neuhaus; Thomas Claudepierre
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.